Abstract:PURPOSE:To assess the potential utility of an integrin αvβ3-targeting radiotracer, technetium 99m-PEG4-E[PEG4-cyclo(arginine-glycine-aspartic acid-D-phenylalanine-lysine)]2 ((99m)Tc-3PRGD2), for single photon emission computed tomography (SPECT)/computed tomography (CT) for monitoring of the progression and prognosis of liver fibrosis in a rat model.MATERIALS AND METHODS:All animal experiments were performed by following the protocol approved by the institutional animal care and use committee. (99m)Tc-3PRGD2 was prepared and longitudinal SPECT/CT was performed to monitor the progression (n = 8) and recovery (n = 5) of liver fibrosis induced in a rat model by means of thioacetamide (TAA) administration. The mean liver-to-background radioactivity per unit volume ratio was analyzed for comparisons between the TAA and control (saline) groups at different stages of liver fibrosis. Data were compared by using Student t and Mann-Whitney tests. Results:of SPECT/CT were compared with those of ex vivo biodistribution analysis (n = 5).RESULTS:Accumulation of (99m)Tc-3PRGD2 in the liver increased in proportion to the progression of fibrosis and TAA exposure time; accumulation levels were significantly different between the TAA and control groups as early as week 4 of TAA administration (liver-to-background ratio: 32.30 ± 3.39 vs 19.01 ± 3.31; P = .0002). Results of ex vivo immunofluorescence staining demonstrated the positive expression of integrin αvβ3 on the activated hepatic stellate cells, and the integrin αvβ3 levels in the liver corresponded to the results of SPECT/CT (R(2) = 0.75, P < .0001). (99m)Tc-3PRGD2 uptake in the fibrotic liver decreased after antifibrotic therapy with interferon α2b compared with that in the control group (relative liver-to-background ratio: 0.45 ± 0.05 vs 1.01 ± 0.05; P < .0001) or spontaneous recovery (relative liver-to-background ratio: 0.56 ± 0.06 vs 1.01 ± 0.05; P < .0001).CONCLUSION:(99m)Tc-3PRGD2 SPECT/CT was successfully used to monitor the progression and recovery of liver fibrosis and shows potential applications for noninvasive diagnosis of early stage liver fibrosis.

Pharmacokinetics and disposition study of calf thymus DNA in rats by applying 3H-labeling method.

Pharmacokinetic Study Of~(125) I-CTLA4Ig:Absorption,distribution,and Excretion after a Single Intravenous Administration to Rats

Plasma Pharmacokinetics and Tissue Distribution Study of Physalin D in Rats by Ultra-Pressure Liquid Chromatography with Tandem Mass Spectrometry

Quantification of paclitaxel in rat plasma by LC-MS/MS and pharmacokinetics of paclitaxel thermosensi-tive liposomes in rats

Direct radio-labeling of 99Tcm-IgG and its biologic distribution study

Blood Clearance Kinetics, Biodistribution, and Radiation Dosimetry of a Kit-Formulated Integrin Αvβ3-Selective Radiotracer 99Mtc-3Prgd2 in Non-Human Primates

Characterization of Interaction of Calf Thymus DNA with Gefitinib: Spectroscopic Methods and Molecular Docking

Molecular complexes of calf thymus DNA with various bioactive compounds: Formation and characterization

Preparation and Biodistribution of ~(99M)tc-Pdgfr-β AODN

Radiolabeling of DNA Bipyramid and Preliminary Biological Evaluation in Mice

Quantification of CPT13 in rat plasma using LC–MS/MS for a pharmacokinetic study

Radiolabeling of Filamentous Phage Peptide Library with ~(99m)tc and Its Biodistribution in Normal Mice

Determination of tectoridin in rat plasma by high-performance liquid chromatography and its application to pharmacokinetic studies.

Pharmaeokinetic Studies of PEG-dipeptide-TNF-α and in Rat Plasma by ~(125)I-Labeled and Extracting Methods

Study on pharmacokinetics and acute toxicity of new molecular probe 99 m Tc-RRL

Radiolabeling and Preliminary Evaluation of 99mTc-Labeled DNA Cube Nanoparticles as Potential Tracers for SPECT Imaging

An Optimized LC-MS/MS Method for Determination of HYNIC-3PRGD2, a New Promising Imaging Agent for Tumor Targeting, in Rat Plasma and Its Application.

Preparation and Preliminary Biological Evaluation of 11C-L-spd

Small-Animal SPECT/CT of the Progression and Recovery of Rat Liver Fibrosis by Using an Integrin Αvβ3-Targeting Radiotracer.

Studies of 99mTc labeled carcinoembyronic antigen monoclonal antibody C50 fragment Fab' and biodistrobution

Pharmacokinetics and Tissue Distribution Study of Caudatin in Normal and Diethylnitrosamine-Induced Hepatocellular Carcinoma Model Rats